Verition Fund Management
SANA icon

Verition Fund Management’s Sana Biotechnology SANA Stock Holding History

Verition Fund Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-125,098
Closed -$683K – 3478
2024
Q2 		$683K Sell
125,098
-259,181
-67% -$2.07M ﹤0.01% 1884
2024
Q1 		$3.84M Sell
384,279
-100,656
-21% -$754K 0.03% 837
2023
Q4 		$1.98M Sell
484,935
-18,226
-4% -$67.1K 0.02% 851
2023
Q3 		$1.95M Buy
503,161
+144,332
+40% +$776K 0.02% 796
2023
Q2 		$2.14M Buy
358,829
+192,738
+116% +$1.11M 0.03% 649
2023
Q1 		$543K Buy
+166,091
New +$664K 0.01% 1194

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return

Verition Fund Management's SANA Position: Q3 2024 in Review

Verition Fund Management sold out of Sana Biotechnology (SANA) in Q3 2024, closing a stake of 125,098 shares — an estimated $683K sold.

Verition Fund Management first reported a position in SANA in Q1 2023 and held it in 6 quarters. The position peaked at $3.84M in Q1 2024. 155 funds tracked by Wall St. Rank hold SANA as of Q3 2024.

  • Verition Fund Management reported no remaining Sana Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Verition Fund Management sold 125,098 Sana Biotechnology shares in Q3 2024, an estimated $683K.
  • Verition Fund Management first reported a position in Sana Biotechnology in Q1 2023 and held it in 6 quarters.
  • Verition Fund Management's Sana Biotechnology position peaked at $3.84M in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2024.

Based on Verition Fund Management's 13F filing for Q3 2024, filed 14 Nov 2024.